Bibliography
Export 2842 results:
Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol. 1996;91(2):376-9.
Posttransplant malaria. Transplantation. 1996;62(10):1521-1523.
Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg. 1996;2(1):52-9.
Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3. Bone Marrow Transplant. 1996;17 Suppl 3:S67-9.
Prolonged thrombocytopenia after administration of granulocyte colony-stimulating factor and leukapheresis in a donor for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1996;18(2):482-3.
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol. 1996;24(7):839-47.
Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation. 1996;62(4):463-6.
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334(26):1685-90.
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion. 1996;36(9):782-8.
Testicular seminoma originating in an undescended testis in a renal allograft recipient. Urology. 1996;48(1):145-8.
Thrombocytopenia in allogeneic peripheral blood stem cell collections. Transfusion. 1996;36(7):668-9.
Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg. 1996;2(4):299-300.
Transfer of embryos from yeast-colonized dishes. Fertil Steril. 1996;66(2):335-7.
Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. British Journal of Haematology. 1996;94(1):155-8.
Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective. Dev Biol Stand. 1996;88:257-64.
Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109(4):1119-24.
Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;18(2):473-474.
Transmission of rabies by corneal graft. Cornea. 1996;15(4):431-3.
Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis. 1996;55(9):638-41.
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant. 1996;17 Suppl 2:S19-21.
Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion. 1996;36(7):601-10.
The use of liver grafts infested with Clonorchis sinensis for orthotopic liver transplantation. Postgrad Med J. 1996;72(849):427-8.
Anomalous ABO inheritance explained by ovum transplantation. Transfusion. 1995;35(1):61-2.
Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors. Surv Ophthalmol. 1995;40(1):80.
Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors. Br J Ophthalmol. 1995;79(1):6-9.